Exercise on Multiple Sclerosis Patients
Effects of Head and Neck Cooling on Functional Ability and Fatigue of Multiple Sclerosis
1 other identifier
interventional
10
1 country
1
Brief Summary
Multiple sclerosis (MS) patients are characterized by thermoregulatory failure, known as Uthoff's phenomenon. Precisely, 60-80% of the MS patients present adverse clinical symptoms when their body temperature is increased. Thus, the development of treatment strategies to overcome the thermoregulatory problem in these patients is crucial. Given that cooling has been proposed as an effective method, the aim of this study was to examine whether the application of head cooling therapy during an exercise training session is capable to prevent the core temperature increase and to improve the patient's functional ability and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Jun 2019
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2019
CompletedFirst Submitted
Initial submission to the registry
October 8, 2019
CompletedFirst Posted
Study publicly available on registry
October 14, 2019
CompletedOctober 14, 2019
October 1, 2019
24 days
October 8, 2019
October 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Core Temperature
The core temperature was measured using a telemetric capsule or (e-Celsius Performance, BodyCap, Caen, France). Temperature at the skin surface was recorded every second at four sites using iBUTTON sensors (type DS1921 H, Maxim/Dallas Semiconductor Corp., USA) \[Tsk; 0.3 (chest C arm) C 0.2 (thigh C leg)\].
Change from baseline to after 40 minutes of continous cycling.
Functional ability test Handgrip
Handgrip dynamometer was used for the upper body muscle strength evaluation. Both hands was tested.
Change from baseline to after 40 minutes of continous cycling.
Functional ability test 2-minute walk
The two-minute walk test was applied where all the patients had to cover as far a distance as possible over 2 minutes. All the walking tests are related with the ability to perform independently the activities of daily living
Change from baseline to after 40 minutes of continous cycling.
Functional ability test 25-Foot Walk (T25-FW)
The 25-Foot Walk (T25-FW) was used to measure the walking speed. It is a validated test that reflects the patient's mobility and leg function performance
Change from baseline to after 40 minutes of continous cycling.
Functional ability test five times sit-to-stand test (STS)
The five times sit-to-stand test (STS) was used as an indicator for lower limb strength, balance and mobility. It has been reported that the STS times are associated with standing and leaning balance and mobility in older people. Slow STS time have been also found to predict subsequent disability, falls and hip fractures
Change from baseline to after 40 minutes of continous cycling.
Functional ability test Berg Balance Scale (BBS)
The Berg Balance Scale (BBS) evaluates the performance in specific activities that require balance function. The BBS test lasts approximately 20 minutes and involves common actions (e.g. sit to stand, picking up an object, standing on one leg e.t.c.) necessary for activities of daily living. The BBS is a 14-item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.
Change from baseline to after 40 minutes of continous cycling.
Functional ability test level of fatigue severity (FSS)
The FSS is a 9-item self-report scale about fatigue of certain activities. Its score includes a 7-point scale from 1 = strongly disagree to 7 = strongly agree. The minimum possible score is nine and the highest is 63. High score indicates severe fatigue. FSS takes approximately eight minutes to complete.
Change from baseline to after 40 minutes of continous cycling.
Functional ability test Cognitive function
Cognitive function was assessed with the mini mental state examination (MMSE) questionnaire. MMSE includes tests of orientation, attention, memory, language and visual-spatial skills. The answers in the MMSE are scored as following: 0=incorrect, 1=correct, 6= item administered, participant does not answer and 9= unknown
Change from baseline to after 40 minutes of continous cycling.
Functional ability test level of fatigue impact
Level of fatigue was assessed by the Modified Fatigue Impact Scale (MFIS). The MFIS contains the following sections: a) Physical Sub-scale (score 0-36), b) Cognitive Sub-scale (score 0-40) and Psychological Sub-scale (score 0-8). The total MFIS score is 0-84; 0 represents the lower score and 84 represents the higher score.
Change from baseline to after 40 minutes of continous cycling.
Functional ability test level of fatigue inventory
Level of fatigue was assessed by the 20-item scale Multidimensional Fatigue Inventory (MFI) questionnaire. The score of MFI is 1-7. The more the fatigue, the higher the score.
Change from baseline to after 40 minutes of continous cycling.
Functional ability test level of physical fatigue
Level of fatigue was assessed by the Cognitive and Physical Fatigue in Multiple Sclerosis Scale (CPF-MS). The CPF-MS score is 1-5. The more the fatigue, the higher the score.
Change from baseline to after 40 minutes of continous cycling.
Study Arms (2)
Exercise with cooling
EXPERIMENTALAssigned Interventions 10 MS patients (aged 25----50 years) with Expanded Disability Status Scale between 2 to 6.5 have agreed to participate in this study. The exercise training session involved head cooling and neck wraps. The exercise training session consisted of 40 min continuous cycling where the participants performed an incremental sub-maximal exercise protocol beginning at 45 W, increasing 10 W every 10 min for a total of four stages on a semirecumbent cycle ergometer in a 20oC room. Before and after the completion of the session each participant performed a variety of functional ability tests. The evaluation of the core temperature and the assessment of the patient's quality of life also was performed.
Exercise without cooling
ACTIVE COMPARATOR10 MS patients (aged 25----50 years) with Expanded Disability Status Scale between 2 to 6.5 have agreed to participate in this study. The exercise session performed without cooling. The exercise training session consisted of 40 min continuous cycling where the participants performed an incremental sub-maximal exercise protocol beginning at 45 W, increasing 10 W every 10 min for a total of four stages on a semirecumbent cycle ergometer in a 20oC room. Before and after the completion of the session each participant performed a variety of functional ability tests. The evaluation of the core temperature and the assessment of the patient's quality of life also was performed.
Interventions
The exercise training session involved head cooling and neck wraps. Participants followed a 40-minute continuous cycling where they performed an incremental sub-maximal exercise protocol beginning at 45 W, increasing 10 W every 10 min for a total of four stages on a semirecumbent cycle ergometer in a 20oC room. Before and after the completion of the condition each participant performed a variety of functional ability tests. The evaluation of the core temperature and the assessment of the patient's quality of life also was performed
The exercise session performed without cooling. Participants followed a 40-minute continuous cycling where they performed an incremental sub-maximal exercise protocol beginning at 45 W, increasing 10 W every 10 min for a total of four stages on a semirecumbent cycle ergometer in a 20oC room. Before and after the completion of the session each participant performed a variety of functional ability tests. The evaluation of the core temperature and the assessment of the patient's quality of life also was performed.
Eligibility Criteria
You may qualify if:
- Postmenopausal women (no menses for the last year at least);
- Osteoporosis patients (female): T-score\<-2.5 at the femoral neck (or other anatomical site);
- Osteoporosis patients (male): T-score\<-2.5 at the femoral neck (or other anatomical site)
- Osteopenia patients (female): T-score\<-1.0 at the femoral neck (or other anatomical site);
- Osteopenia patients (male): T-score\<-1.0 at the femoral neck (or other anatomical site)
- Patients taking drugs/ supplements for osteoporosis will be accepted in the study after going through a wash-up period
You may not qualify if:
- Women with irregular menses (i.e. with no established menopause)
- Patients taking medications for other diseases known to interfere with bone metabolism
- Patients with other chronic diseases (e.g. diabetes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Petros Dinaslead
Study Sites (1)
FAME Lab, Department of Exercise Science, University of Thessaly
Trikala, Thessaly, 42100, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonia Kaltsatou, PhD
FAME Laboratory, Department of Exercise Science, University of Thessaly
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Researcher in human physiology
Study Record Dates
First Submitted
October 8, 2019
First Posted
October 14, 2019
Study Start
June 1, 2019
Primary Completion
June 25, 2019
Study Completion
June 25, 2019
Last Updated
October 14, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share